The US Food and Drug Administration (FDA) has cleared Hong Kong-based Filligent's BioFriend BioMask surgical face masks.
Illinois-based Medline Industries distributes BioMask to hospitals, nursing homes, surgery centers, hospitality and retail chains across the US, in addition to Canada and Europe.
The hydrophilic plastic coating of the BioMask absorbs aerosol droplets away from the outer surface of the mask.
To inactivate influenza viruses the first and second layers of the mask are treated with different compounds.
Upon five minutes contact, the mask inactivated influenza viruses like A subtypes and strains, H1N1, H3N2, H2N2; avian flu subtypes H5N1, H9N2, H5N2; swine flu subtype H1N1; equine flu subtype H3N8; and Influenza B, under independent laboratory (in vitro) tests.
Medline Proxima Division president Frank Czajka said they are excited to provide a mask that reduces cross contamination, and give healthcare facility staff and patients a level of safety and security.